
Eli Lilly Surges on China Expansion Despite Supreme Court Lawsuit Setback
Eli Lilly announces $3B China investment and Mounjaro reimbursement win, but faces multibillion-dollar lawsuit over Actos disclosures.
LLYAAPLTAKclass action lawsuitMounjaro


Investing.com··Jeffrey Neal Johnson